Trial Profile
Planned phase II trial of sGC 1061.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2013
Price :
$35
*
At a glance
- Drugs SGC 1061 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 04 Jul 2013 New trial record